Developer docs
API playgroundTry for free, no card

Search company profiles

Pharmaceuticals Export Promotion Council of India

Full company profile

uuid000hnls

Namestring
Pharmaceuticals Export Promotion Council of India
Legal namestring
Pharmaceuticals Export Promotion Council of India
Websiteurl
pharmexcil.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) is a government-backed, non-profit Export Promotion Council established under the Department of Commerce, Ministry of Commerce & Industry, Government of India. It functions as the nodal agency for Indian pharmaceutical exporters, providing trade facilitation, certification, market intelligence, and policy advocacy services to a membership base of Indian generic-drug manufacturers, APIs producers, and pharmaceutical MSMEs. The organization is operationally headquartered in Hyderabad with a regional outreach office in Mumbai, employing 51-100 staff. (Note: founding year is reported inconsistently across inputs — 2004 in firmographics versus a 2009 website copyright/establishment record.)

The council's service surface is organized around four pillars: regulatory and trade documentation (Certificate of Origin issuance, online certificate verification), administration of government export-subsidy schemes (Market Development Assistance / Market Access Initiative — MDA/MAI), market and regulatory intelligence (country-wise drug registration reports, trade statistics, an export performance dashboard), and a member directory with trade-enquiry matchmaking. It also operates flagship convening platforms including the iPHEX exhibition, the India Pharma API Summit, and Chintan Shivir strategy forums, and publishes the Pharmexcil Digest. Underlying technology is a web-based council platform; there are no proprietary technical components, APIs, mobile app, or AI capabilities disclosed.

Pharmexcil does not operate as a commercial entity and generates no trading revenue — the export figures cited in source materials (e.g., $30.47B in FY2024-25 pharma exports) refer to the broader Indian pharmaceutical sector, not the council itself. Its own revenue mechanics are membership-based (recurring RCMC/membership fees, subscription-recurring model) supplemented by transaction-fee income from exhibition stall bookings and event sponsorship (iPHEX, India Pavilion at CPHI Worldwide, Arab Health). Operations are additionally funded by the Government of India. Go-to-market is sales-led and events-driven, channeled through international exhibitions, bilateral pharma business meets, and direct government liaison; membership pricing is not publicly disclosed.

Short descriptiontext

Government-backed non-profit export promotion council and nodal agency under India's Ministry of Commerce, providing certification, MDA/MAI scheme administration, market intelligence, trade events, and policy advocacy to Indian pharmaceutical exporters and MSMEs targeting global regulated and emerging markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHyderabad, India
HQ citystring
Hyderabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical export promotion, trade certification services, market development assistance, regulatory compliance support, export facilitation services
Industry2 codes
1Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)
CodeHLAIAJAFPrimaryYes
2Healthcare/Pharma Creative Agencies
CodeMPAAAAAJPrimaryNo
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Export Promotion Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Membership Services
TypeSubscription Recurring
Description

Pharmexcil operates as a membership-based organization providing services to pharmaceutical exporters including certification of origin, trade information, and representation to government bodies.

pharmexcil.com
2Event Participation and Sponsorship
TypeTransaction Fee
Description

Revenue generated from stall bookings at exhibitions like iPHEX, CPHI Worldwide, and other pharma events organized or facilitated by the council.

pharmexcil.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Pharmexcil is a government export promotion council that supports Indian pharmaceutical exporters through issuance of Certificates of Origin, administration of MDA/MAI government subsidy schemes, country-specific regulatory and market intelligence, a member directory with trade enquiry functionality, and online certificate verification. It also organizes flagship export events such as iPHEX and Chintan Shivir consultation forums, and publishes the Pharmexcil Digest. The council acts as the nodal agency for pharma trade facilitation and government representation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Organized Peru-India Pharmexcil 2026 Business Roundtable with 1,015 B2B meetings between Peruvian companies and 81 Indian manufacturers
+2 more records
Product overview1 text field

Pharmexcil operates as an export promotion council, not a product company. It provides a suite of trade facilitation services organized around certification, market intelligence, event coordination, and member support. The core offerings include Certificate of Origin issuance, MDA/MAI scheme administration for export subsidies, a member directory with trade enquiry functionality, and regulatory/market information by country. The organization also runs flagship export events like IPHEX and strategic consultation forums (Chintan Shivir), while publishing the Pharmexcil Digest for industry updates. An online certificate verification service supports trade authenticity.

Product and service1 record
1Certification of Origin
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-06-16
Description

Armenia's Universal Health Care Scheme opening oncology drug export opportunities. Pharmexcil facilitating Indian pharma companies interested in supplying products through PharmaExcel, with Ministry providing support in product registration process.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-24
Description

IPC signed MoUs with PMBI and NIPER Hajipur to strengthen drug quality assurance, research collaboration, and pharmacovigilance. Joint research in pharmaceutical sciences including impurity profiling and development of analytical methods for biologics and biosimilars.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-24
Description

MoU with NIPER focuses on joint research in pharmaceutical sciences including impurity profiling, development of analytical methods for biologics and biosimilars, and faculty exchange initiatives.

4Kazakhstan Pharma Industry
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-03-28
Description

India-Kazakhstan Pharma Business Meet held on 28 March 2026 for pharmaceutical cooperation and market access discussions.

uzdaily.uz
5Uzbekistan Government/Pharma Industry
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-25
Description

Organized India-Uzbekistan Pharma Business Meet in Tashkent to expand cooperation in pharmaceutical sector. Focused on production localization, technology transfer, and accessing Central Asian markets through Tashkent Pharma Park (Bio Pharma City) cluster.

uzdaily.uz
6Belarus Pharma Industry
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-03-19
Description

India-Belarus Pharma Business Meet held on 19 March 2026 for pharmaceutical cooperation discussions.

uzdaily.uz
7Russia Pharma Industry
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-03-16
Description

India-Russia Pharma Business Meet held on 16 March 2026 for pharmaceutical cooperation and market access.

uzdaily.uz
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-23
Description

Jointly organized Peru-India Pharmexcil 2026 Business Roundtable facilitating 1,015 B2B meetings between Peruvian companies and 81 Indian pharmaceutical manufacturers. Peru imported $73 million worth of pharmaceuticals from India in the previous year, representing 27% growth.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sister Export Promotion Council under India's Ministry of Commerce & Industry, mandated to promote exports of chemicals, cosmetics, dyes and allied products. Operates the identical EPC model — certification of origin, MDA/MAI scheme administration, market intelligence, and bilateral business meets — making it the closest functional peer to Pharmexcil.

TypeBroad incumbent
Description

National EPC for engineering goods under the same Department of Commerce framework as Pharmexcil. Runs comparable member services — export certification, market access initiatives, trade delegations and iCube/iSource platforms — but covers a much larger capital-goods category rather than pharmaceuticals.

TypeBroad incumbent
Description

Statutory export body under India's Ministry of Commerce handling agricultural and processed food exports. Operates with similar mechanisms of certification, market development schemes, and international buyer-seller meets; a peer institution rather than a direct competitor.

TypeBroad incumbent
Description

India's EPC for gems and jewellery, organizing flagship trade shows (IIJS) and bilateral buyer meets analogous to iPHEX. Same EPC governance structure and MDA/MAI scheme access, but focused on a different merchandise vertical.

TypeBroad incumbent
Description

Cotton textiles EPC under India's Ministry of Commerce. Provides member certification, market information and trade fair facilitation along a similar operating playbook to Pharmexcil, though serving textile exporters rather than pharma.

TypeBroad incumbent
Description

India's EPC for services exports. Operates member services and trade facilitation using the same institutional framework as Pharmexcil, but for intangible services rather than pharmaceutical goods.

TypeEmerging player
Description

India's handloom products EPC under the Ministry of Textiles. Smaller and more sector-narrow than Pharmexcil, but provides comparable export-promotion services for its member base.

TypeEmerging player
Description

India's EPC for plastics exports. Like Pharmexcil, runs export facilitation, certification and international trade fairs for its members, though in a different product category.

TypeRegional player
Description

Government-affiliated trade and investment promotion body for Japanese exporters and inward investors. Comparable mandate of export facilitation, market intelligence and international business matching, but operating from Japan for Japanese — not Indian — firms.

TypeRegional player
Description

China's national trade promotion council linking government, exporters and overseas buyers. Runs analogous exhibitions, certification services and trade dispute support — comparable function but covers all Chinese export sectors and operates from China.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pharmaceuticals Export Promotion Council of India

Pharmaceutical Export Promotion Servicespharmexcil.com

Government-backed non-profit export promotion council and nodal agency under India's Ministry of Commerce, providing certification, MDA/MAI scheme administration, market intelligence, trade events, and policy advocacy to Indian pharmaceutical exporters and MSMEs targeting global regulated and emerging markets.

What Pharmaceuticals Export Promotion Council of India does

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) is a government-backed, non-profit Export Promotion Council established under the Department of Commerce, Ministry of Commerce & Industry, Government of India. It functions as the nodal agency for Indian pharmaceutical exporters, providing trade facilitation, certification, market intelligence, and policy advocacy services to a membership base of Indian generic-drug manufacturers, APIs producers, and pharmaceutical MSMEs. The organization is operationally headquartered in Hyderabad with a regional outreach office in Mumbai, employing 51-100 staff. (Note: founding year is reported inconsistently across inputs — 2004 in firmographics versus a 2009 website copyright/establishment record.)

The council's service surface is organized around four pillars: regulatory and trade documentation (Certificate of Origin issuance, online certificate verification), administration of government export-subsidy schemes (Market Development Assistance / Market Access Initiative — MDA/MAI), market and regulatory intelligence (country-wise drug registration reports, trade statistics, an export performance dashboard), and a member directory with trade-enquiry matchmaking. It also operates flagship convening platforms including the iPHEX exhibition, the India Pharma API Summit, and Chintan Shivir strategy forums, and publishes the Pharmexcil Digest. Underlying technology is a web-based council platform; there are no proprietary technical components, APIs, mobile app, or AI capabilities disclosed.

Pharmexcil does not operate as a commercial entity and generates no trading revenue — the export figures cited in source materials (e.g., $30.47B in FY2024-25 pharma exports) refer to the broader Indian pharmaceutical sector, not the council itself. Its own revenue mechanics are membership-based (recurring RCMC/membership fees, subscription-recurring model) supplemented by transaction-fee income from exhibition stall bookings and event sponsorship (iPHEX, India Pavilion at CPHI Worldwide, Arab Health). Operations are additionally funded by the Government of India. Go-to-market is sales-led and events-driven, channeled through international exhibitions, bilateral pharma business meets, and direct government liaison; membership pricing is not publicly disclosed.

Pharmaceuticals Export Promotion Council of India firmographics

Firmographics
Name
Pharmaceuticals Export Promotion Council of India
Legal name
Pharmaceuticals Export Promotion Council of India
Website
https://pharmexcil.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
51–100 employees
Short description
Government-backed non-profit export promotion council and nodal agency under India's Ministry of Commerce, providing certification, MDA/MAI scheme administration, market intelligence, trade events, and policy advocacy to Indian pharmaceutical exporters and MSMEs targeting global regulated and emerging markets.
Ownership category
akta.pro rank

Pharmaceuticals Export Promotion Council of India industry classification

Industry
Product category
Pharmaceutical Export Promotion Services
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)
akta.pro secondary industry
Healthcare/Pharma Creative Agencies (MPAAAAAJ)

Keywords

  • Pharmaceutical export promotion
  • Trade certification services
  • Market development assistance
  • Regulatory compliance support
  • Export facilitation services

Where Pharmaceuticals Export Promotion Council of India is headquartered

Location

Headquarters

HQ city
Hyderabad
HQ country
India
HQ region
Asia

Offices2 records

Markets served

Pharmaceuticals Export Promotion Council of India business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Membership Services: Pharmexcil operates as a membership-based organization providing services to pharmaceutical exporters including certification of origin, trade information, and representation to government bodies.
  2. Event Participation and Sponsorship: Revenue generated from stall bookings at exhibitions like iPHEX, CPHI Worldwide, and other pharma events organized or facilitated by the council.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Pharmaceuticals Export Promotion Council of India product offering

Product offering

Core offering

Pharmexcil is a government export promotion council that supports Indian pharmaceutical exporters through issuance of Certificates of Origin, administration of MDA/MAI government subsidy schemes, country-specific regulatory and market intelligence, a member directory with trade enquiry functionality, and online certificate verification. It also organizes flagship export events such as iPHEX and Chintan Shivir consultation forums, and publishes the Pharmexcil Digest. The council acts as the nodal agency for pharma trade facilitation and government representation.

Product overview

Pharmexcil operates as an export promotion council, not a product company. It provides a suite of trade facilitation services organized around certification, market intelligence, event coordination, and member support. The core offerings include Certificate of Origin issuance, MDA/MAI scheme administration for export subsidies, a member directory with trade enquiry functionality, and regulatory/market information by country. The organization also runs flagship export events like IPHEX and strategic consultation forums (Chintan Shivir), while publishing the Pharmexcil Digest for industry updates. An online certificate verification service supports trade authenticity.

Differentiator

Problem solved

Functional benefit

Products and services

  • Certification of Origin

Quantifiable outcome

  • Organized Peru-India Pharmexcil 2026 Business Roundtable with 1,015 B2B meetings between Peruvian companies and 81 Indian manufacturers
  • +2 more outcomes

Companies that use Pharmaceuticals Export Promotion Council of India

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Pharmaceuticals Export Promotion Council of India technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Pharmaceuticals Export Promotion Council of India partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered minor and core.

  • Armenia Ministry of HealthminorStrategic or Co-development Partner · 16 June 2026Armenia's Universal Health Care Scheme opening oncology drug export opportunities. Pharmexcil facilitating Indian pharma companies interested in supplying products through PharmaExcel, with Ministry providing support in product registration process.
  • Indian Pharmacopoeia Commission (IPC)coreStrategic or Co-development Partner · 24 April 2026IPC signed MoUs with PMBI and NIPER Hajipur to strengthen drug quality assurance, research collaboration, and pharmacovigilance. Joint research in pharmaceutical sciences including impurity profiling and development of analytical methods for biologics and biosimilars.
  • National Institute of Pharmaceutical Education and Research (NIPER) HajipurcoreStrategic or Co-development Partner · 24 April 2026MoU with NIPER focuses on joint research in pharmaceutical sciences including impurity profiling, development of analytical methods for biologics and biosimilars, and faculty exchange initiatives.
  • Kazakhstan Pharma IndustryminorStrategic or Co-development Partner · 28 March 2026India-Kazakhstan Pharma Business Meet held on 28 March 2026 for pharmaceutical cooperation and market access discussions.
  • Uzbekistan Government/Pharma IndustrycoreStrategic or Co-development Partner · 25 March 2026Organized India-Uzbekistan Pharma Business Meet in Tashkent to expand cooperation in pharmaceutical sector. Focused on production localization, technology transfer, and accessing Central Asian markets through Tashkent Pharma Park (Bio Pharma City) cluster.
  • Belarus Pharma IndustryminorStrategic or Co-development Partner · 19 March 2026India-Belarus Pharma Business Meet held on 19 March 2026 for pharmaceutical cooperation discussions.
  • Russia Pharma IndustryminorStrategic or Co-development Partner · 16 March 2026India-Russia Pharma Business Meet held on 16 March 2026 for pharmaceutical cooperation and market access.
  • Lima Chamber of CommercecoreStrategic or Co-development Partner · 23 February 2026Jointly organized Peru-India Pharmexcil 2026 Business Roundtable facilitating 1,015 B2B meetings between Peruvian companies and 81 Indian pharmaceutical manufacturers. Peru imported $73 million worth of pharmaceuticals from India in the previous year, representing 27% growth.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Pharmaceuticals Export Promotion Council of India competitors and assessment

Company assessment

Direct peers

  • CHEMEXCIL (Chemicals Export Promotion Council of India): Sister Export Promotion Council under India's Ministry of Commerce & Industry, mandated to promote exports of chemicals, cosmetics, dyes and allied products. Operates the identical EPC model — certification of origin, MDA/MAI scheme administration, market intelligence, and bilateral business meets — making it the closest functional peer to Pharmexcil.

Broad incumbents

  • EEPC India (Engineering Export Promotion Council): National EPC for engineering goods under the same Department of Commerce framework as Pharmexcil. Runs comparable member services — export certification, market access initiatives, trade delegations and iCube/iSource platforms — but covers a much larger capital-goods category rather than pharmaceuticals.
  • APEDA (Agricultural & Processed Food Products Export Development Authority): Statutory export body under India's Ministry of Commerce handling agricultural and processed food exports. Operates with similar mechanisms of certification, market development schemes, and international buyer-seller meets; a peer institution rather than a direct competitor.
  • GJEPC (Gem & Jewellery Export Promotion Council): India's EPC for gems and jewellery, organizing flagship trade shows (IIJS) and bilateral buyer meets analogous to iPHEX. Same EPC governance structure and MDA/MAI scheme access, but focused on a different merchandise vertical.
  • TEXPROCIL (Cotton Textiles Export Promotion Council): Cotton textiles EPC under India's Ministry of Commerce. Provides member certification, market information and trade fair facilitation along a similar operating playbook to Pharmexcil, though serving textile exporters rather than pharma.
  • SEPC (Services Export Promotion Council): India's EPC for services exports. Operates member services and trade facilitation using the same institutional framework as Pharmexcil, but for intangible services rather than pharmaceutical goods.

Emerging players

  • Handloom Export Promotion Council (HEPC): India's handloom products EPC under the Ministry of Textiles. Smaller and more sector-narrow than Pharmexcil, but provides comparable export-promotion services for its member base.
  • Plastic Export Promotion Council (Plexconcil): India's EPC for plastics exports. Like Pharmexcil, runs export facilitation, certification and international trade fairs for its members, though in a different product category.

Regional players

  • JETRO (Japan External Trade Organization): Government-affiliated trade and investment promotion body for Japanese exporters and inward investors. Comparable mandate of export facilitation, market intelligence and international business matching, but operating from Japan for Japanese — not Indian — firms.
  • CCPIT (China Council for the Promotion of International Trade): China's national trade promotion council linking government, exporters and overseas buyers. Runs analogous exhibitions, certification services and trade dispute support — comparable function but covers all Chinese export sectors and operates from China.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Pharmaceuticals Export Promotion Council of India social profiles

Digital presence

Pharmaceuticals Export Promotion Council of India financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pharmaceuticals Export Promotion Council of India leadership team

Management profile

Number of profiles

Profiles9 records

Pharmaceuticals Export Promotion Council of India funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pharmaceuticals Export Promotion Council of India M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmaceuticals Export Promotion Council of India

What does Pharmaceuticals Export Promotion Council of India do?

Pharmexcil is a government export promotion council that supports Indian pharmaceutical exporters through issuance of Certificates of Origin, administration of MDA/MAI government subsidy schemes, country-specific regulatory and market intelligence, a member directory with trade enquiry functionality, and online certificate verification. It also organizes flagship export events such as iPHEX and Chintan Shivir consultation forums, and publishes the Pharmexcil Digest. The council acts as the nodal agency for pharma trade facilitation and government representation.

Is Pharmaceuticals Export Promotion Council of India a public or private company?

Pharmaceuticals Export Promotion Council of India is a private company. It is classified as state government owned and is currently operating.

When was Pharmaceuticals Export Promotion Council of India founded?

Pharmaceuticals Export Promotion Council of India was founded in 2009. It employs 51 to 100 people.

Where is Pharmaceuticals Export Promotion Council of India based?

Pharmaceuticals Export Promotion Council of India is headquartered in Hyderabad, India, in the Asia region.

How does Pharmaceuticals Export Promotion Council of India make money?

Two revenue lines are on record. Membership Services are the primary driver. The others are event Participation and Sponsorship.

Who are Pharmaceuticals Export Promotion Council of India's main competitors?

CHEMEXCIL (Chemicals Export Promotion Council of India) is listed as a direct peer. Broad incumbents are EEPC India (Engineering Export Promotion Council), APEDA (Agricultural & Processed Food Products Export Development Authority), GJEPC (Gem & Jewellery Export Promotion Council), TEXPROCIL (Cotton Textiles Export Promotion Council) and SEPC (Services Export Promotion Council). Emerging players are Handloom Export Promotion Council (HEPC) and Plastic Export Promotion Council (Plexconcil). Regional players are JETRO (Japan External Trade Organization) and CCPIT (China Council for the Promotion of International Trade).

Does Pharmaceuticals Export Promotion Council of India have an API?

No public API is recorded for Pharmaceuticals Export Promotion Council of India.

What industry is Pharmaceuticals Export Promotion Council of India in?

Pharmaceuticals Export Promotion Council of India's product category is Pharmaceutical Export Promotion Services. Its primary akta.pro industry code is HLAIAJAF, Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor), with a secondary code of MPAAAAAJ, Healthcare/Pharma Creative Agencies. Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Indian Economic ObserverCBN and Pharmexcil sign MoU to regulate controlled substances in Pharma exportsThe Central Bureau of Narcotics and the Pharmaceuticals Export Promotion Council of India signed a Memorandum of Understanding on August 25 in Gwalior to prevent diversion of controlled substances in pharmaceutical exports. The voluntary, non-binding Code of Conduct will be disseminated to exporter members, with joint workshops and a six-month action plan. It follows earlier CBN MoUs with the Indian Chemical Council and CHEMEXCIL.Ani NewsCBN and Pharmexcil sign MoU to regulate controlled substances in Pharma exportsThe Central Bureau of Narcotics and the Pharmaceuticals Export Promotion Council of India signed a Memorandum of Understanding on August 25, 2026, in Gwalior to prevent diversion of controlled substances in pharmaceutical exports. The CBN's voluntary, non-binding Code of Conduct will be disseminated to exporter members, with joint workshops and a six-month action plan. It follows earlier CBN MoUs with the Indian Chemical Council and CHEMEXCIL.The Times of IndiaDrug formulations & biologicals keep India's pharma exports healthy in Q1India's pharmaceutical exports grew 6.8% to $8.10 billion in the first quarter of fiscal 2027, driven primarily by drug formulations and biologicals which contributed nearly three-fourths of the total value. Pharmexcil reported that vaccines were the standout performer with a 35.7% increase, while North America, Europe, Africa, and Latin America accounted for approximately 75% of these shipments. The United States remained the largest single destination, absorbing 34.3% of total exports.The Times of IndiaIndia’s pharmaceutical exports rise 6.8% in Q1 FY27 on global demandIndia’s pharmaceutical exports increased by 6.8% to $8.1 billion in the first quarter of FY27, driven by strong global demand for formulations, bulk drugs, and vaccines, according to the Pharmaceuticals Export Promotion Council of India (Pharmexcil). The United States remained the largest country-level market with a 34.3% share of regional exports, while vaccine exports saw the fastest growth at 35.68%. Industry leaders emphasized that sustaining this momentum requires continued investment in advanced manufacturing and regulatory compliance.KNN IndiaIndia’s Pharma Exports Hit USD 8.10 Bn In Q1 FY27, Up 6.8% YoY: PharmexcilIndia's pharmaceutical exports increased by 6.8% year-on-year in the first quarter of FY27, reaching USD 8.10 billion, according to the Pharmaceuticals Export Promotion Council of India (Pharmexcil). The growth was attributed to rising shipments in vaccines, bulk drugs, and drug intermediates, with the U.S. accounting for the largest share at 30.89%. Pharmexcil emphasized the need for product diversification and regulatory compliance to maintain this momentum in export growth.BusinessLineIndia pharma exports rise 6.8% to $8.1 billion in Q1 FY27; vaccine shipments jump 36%India's pharmaceutical exports rose 6.80 percent to $8.10 billion in the first quarter of FY27, driven by significant increases in vaccine shipments and bulk drugs. Vaccine exports surged 35.68 percent, while drug formulations accounted for the largest share at $5.98 billion. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) emphasized the need for continued product diversification and regulatory compliance to maintain growth momentum.Indian Economic ObserverIndia pharma exports rise 6.8% to USD 8.1 bn in Q1 FY27; vaccine shipments jump 36%India's pharmaceutical exports increased by 6.8% to USD 8.1 billion in the first quarter of FY27, driven by a 35.68% surge in vaccine shipments and growth in bulk drugs. The United States remained the largest destination market, accounting for over 30% of total exports, while North America, Europe, Africa, and Latin America collectively represented nearly 75% of the volume. Pharmexcil emphasized that maintaining this momentum requires continued product diversification and regulatory compliance across key segments like generics and biosimilars.BW DisruptPharma Exports Rise 6.8% To $8.1 Bn In April-June QuarterIndia’s pharmaceutical exports increased by 6.80% year-on-year to $8.10 billion in the first quarter of FY27, driven by growth across key product categories including formulations and vaccines. The United States remained the largest destination, absorbing nearly 31% of total shipments worth $2.5 billion, while North America accounted for over a third of the market. Pharmexcil emphasized that sustaining this momentum requires diversification into complex generics and innovation-led segments alongside continued regulatory compliance.BusinessLineIndia pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body saysIndia's pharmaceutical industry is now projected to reach only $80-90 billion by 2030, well below its stated target of $130 billion set in April last year, according to Namit Joshi, chairman of the Pharmaceuticals Export Promotion Council of India (Pharmexcil). U.S. pharma exports declined to $9.7 billion in the financial year ended March 2026 from $10.5 billion a year earlier, pressured by tariff uncertainty and Red Sea shipping disruptions that forced longer, costlier routes. The industry expects annual growth of 6-10% over the next three years before potentially reaching double digits as higher-value products like biosimilars and peptides gain market share.MarketScreenerIndia pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body saysIndia's pharmaceutical industry is expected to miss its 2030 sales target of $130 billion, now projected to reach only $80-90 billion, according to the Pharmaceuticals Export Promotion Council of India. U.S. pharma shipments fell to $9.7 billion in the financial year ended March 2026 from $10.5 billion a year earlier due to tariff uncertainty and Red Sea shipping disruptions forcing longer routes. The sector may see 6-10% annual growth over the next three years before reaching double digits, with higher-value products like biosimilars and peptides expected to drive future gains.